{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:40:45Z","timestamp":1790836845676,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.clinre.2022.101892","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T01:48:55Z","timestamp":1645408135000},"page":"101892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: Results from a 3-year survey in an Italian tertiary-care hospital"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-2353","authenticated-orcid":false,"given":"Flora","family":"De Conto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Buttrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Loretana","family":"Dell'Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Maccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Arcangeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Chezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2022.101892_bib0001","unstructured":"World Health Organization. World hepatitis day 2020 (Accessed on February 5, 2021) n.d.: https:\/\/www.who.int\/campaigns\/world-hepatitis-day\/."},{"key":"10.1016\/j.clinre.2022.101892_bib0002","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jmv.10092","article-title":"Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination","volume":"67","author":"Mele","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0003","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.dld.2005.07.002","article-title":"Trends of aetiological factors of hepatocellular carcinoma in Italy","volume":"37","author":"Stroffolini","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2022.101892_bib0004","unstructured":"European Centre for Disease Prevention and Control. Hepatitis B. In: ECDC. Annual epidemiological report for 2018. 2020."},{"key":"10.1016\/j.clinre.2022.101892_bib0005","unstructured":"Report ISTAT. Demografia in cifre (Accessed on 27 July 2020) n.d.: http:\/\/demo.istat.it\/."},{"key":"10.1016\/j.clinre.2022.101892_bib0006","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/M17-0377","article-title":"Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: a review of cases reported to the U.S. food and drug administration adverse event reporting system","volume":"166","author":"Bersoff-Matcha","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2022.101892_bib0007","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2016.06.023","article-title":"Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents","volume":"15","author":"Wang","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2022.101892_bib0008","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3748\/wjg.v12.i8.1255","article-title":"Serological pattern \u201canti-HBc alone\u201d: characterization of 552 individuals and clinical significance","volume":"12","author":"Kn\u00f6ll","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2468-1253(16)30076-0","article-title":"Significance of anti-HBc alone serological status in clinical practice","volume":"2","author":"Wang","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2022.101892_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0140-6736(92)90067-D","article-title":"Post-transfusion fulminant hepatitis B after screening for hepatitis B virus core antibody","volume":"339","author":"Yoshiba","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2022.101892_bib0011","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1478-3231.2011.02481.x","article-title":"Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis","volume":"32","author":"Shi","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2022.101892_bib0012","first-page":"15","article-title":"The clinical significance of occult HBV infection","volume":"27","author":"Squadrito","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0013","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13256-015-0630-8","article-title":"Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report","volume":"9","author":"Ende","year":"2015","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.clinre.2022.101892_bib0014","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/522173","article-title":"Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy","volume":"45","author":"Sheng","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2022.101892_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/599610","article-title":"Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women","volume":"49","author":"French","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2022.101892_bib0016","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhin.2007.04.010","article-title":"Hepatitis B virus DNA in serum of \u2019anti-HBc only\u2019-positive healthy Lebanese blood donors: significance and possible implications","volume":"66","author":"El-Zaatari","year":"2007","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.clinre.2022.101892_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-230X-14-31","article-title":"Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma","volume":"14","author":"Masarone","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0018","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12876-014-0214-x","article-title":"Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis","volume":"14","author":"Morisco","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0019","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jiph.2018.10.004","article-title":"Migration and health: a retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the infectious diseases unit of Modena, Italy","volume":"12","author":"Cuomo","year":"2019","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.clinre.2022.101892_bib0020","unstructured":"Azienda Ospedaliero-Universitaria di Parma. L'ospedale. Web page: https:\/\/www.ao.pr.it\/chi-siamo\/lospedale\/ (Date Accessed 2020-07-31) 2021:https:\/\/www.ao.pr.it\/chi-siamo\/lospedale\/."},{"key":"10.1016\/j.clinre.2022.101892_bib0021","unstructured":"Provincia di Parma. Cresce la popolazione del Parmense. 2020. Web page: http:\/\/www.provincia.parma.it\/notizie\/cresce-la-popolazione-del-parmense (Date Accessed 2020-07-31) n.d.: http:\/\/www.provincia.parma.it\/notizie\/cresce-la-po."},{"key":"10.1016\/j.clinre.2022.101892_bib0022","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcv.2016.02.017","article-title":"Evolving strategy for HCV testing in an Italian tertiary care hospital","volume":"77","author":"Medici","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0023","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.tim.2015.02.007","article-title":"Hepatitis C virus screening to reveal a better picture of infection","volume":"23","author":"Medici","year":"2015","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.clinre.2022.101892_bib0024","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s00705-016-2975-8","article-title":"Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy","volume":"161","author":"De Conto","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00705-009-0559-6","article-title":"The underlying mechanisms for the \u201canti-HBc alone\u201d serological profile","volume":"155","author":"Pond\u00e9","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0026","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2022.101892_bib0027","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jvh.12305","article-title":"Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American association for the study of liver diseases","volume":"22","author":"Hwang","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2022.101892_bib0028","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/oxfordjournals.aje.a113680","article-title":"Prevalence of hepatitis B markers in Italy","volume":"118","author":"Pasquini","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinre.2022.101892_bib0029","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","article-title":"Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy","volume":"20","author":"Sagnelli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0030","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0264-410X(98)00414-9","article-title":"Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness","volume":"17","author":"Da Villa","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.clinre.2022.101892_bib0031","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MCG.0b013e318030e3ab","article-title":"Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population","volume":"42","author":"Fabris","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0032","doi-asserted-by":"crossref","first-page":"30009","DOI":"10.2807\/1560-7917.ES.2015.20.35.30009","article-title":"Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013","volume":"20","author":"Coppola","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.clinre.2022.101892_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2003-37583","article-title":"Epidemiology and prevention of hepatitis B","volume":"23","author":"Alter","year":"2003","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2022.101892_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195045","article-title":"High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: virological characteristics associated with poor immune clearance","volume":"13","author":"Malagnino","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2022.101892_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jmv.21121","article-title":"Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?","volume":"80","author":"Vitale","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0036","first-page":"535","article-title":"Hepatitis B virus serum markers (HBsAg, antiHBs, antiHBc): prevalence among drug addicts in north-east Italy","volume":"60","author":"Floreani","year":"1981","journal-title":"Boll Ist Sieroter Milan"},{"key":"10.1016\/j.clinre.2022.101892_bib0037","first-page":"36","article-title":"HBV infection in chronic alcoholics. A survey on 287 cases","volume":"67","author":"Galli","year":"1988","journal-title":"Boll Ist Sieroter Milan"},{"key":"10.1016\/j.clinre.2022.101892_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190775","article-title":"First report of occult hepatitis B infection among ART na\u00efve HIV seropositive individuals in Maputo, Mozambique","volume":"13","author":"Carimo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2022.101892_bib0039","first-page":"344","article-title":"Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects","volume":"10","author":"De Paschale","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.clinre.2022.101892_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.11604\/pamj.supp.2017.27.3.11546","article-title":"Is hepatitis B birth dose vaccine needed in Africa?","volume":"27","author":"Tamandjou","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.clinre.2022.101892_bib0041","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0168-8278(05)80207-7","article-title":"Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity","volume":"17","author":"S\u00e1nchez-Quijano","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.101892_bib0042","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0168-8278(95)80305-X","article-title":"Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus","volume":"23","author":"Jilg","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.101892_bib0043","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00277-009-0806-7","article-title":"Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients","volume":"89","author":"Pei","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinre.2022.101892_bib0044","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12185-015-1750-z","article-title":"Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy","volume":"101","author":"Totani","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clinre.2022.101892_bib0045","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1128\/jvi.67.10.5823-5832.1993","article-title":"Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells","volume":"67","author":"Shih","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0046","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/JCM.36.7.2084-2086.1998","article-title":"Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection","volume":"36","author":"Chu","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2022.101892_bib0047","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.1057","article-title":"HCV genotype and \u201csilent\u201d HBV coinfection: two main risk factors for a more severe liver disease","volume":"64","author":"Sagnelli","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0048","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcv.2005.04.003","article-title":"High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa","volume":"35","author":"Mphahlele","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinre.2022.101892_bib0049","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.101892_bib0050","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1537-2995.2008.01701.x","article-title":"Hepatitis B virus infection and transfusion medicine: science and the occult","volume":"48","author":"Hollinger","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.clinre.2022.101892_bib0051","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3748\/wjg.v17.i12.1549","article-title":"Clinical significance of occult hepatitis B virus infection","volume":"17","author":"Romero","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2022.101892_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131912","article-title":"Occult hepatitis B virus infection in nigerian blood donors and hepatitis B virus transmission risks","volume":"10","author":"Oluyinka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2022.101892_bib0053","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000460301","article-title":"Occult hepatitis infection in transfusion medicine: screening policy and assessment of current use of Anti-HBc testing","volume":"44","author":"Esposito","year":"2017","journal-title":"Transfus Med Hemotherapy"},{"key":"10.1016\/j.clinre.2022.101892_bib0054","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2015.06.016","article-title":"Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy","volume":"63","author":"Spreafico","year":"2015","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2022.101892_bib0055","first-page":"s63","article-title":"Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination","volume":"12","author":"Gessoni","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.clinre.2022.101892_bib0056","first-page":"281","article-title":"Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection","volume":"11","author":"Roman\u00f2","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.clinre.2022.101892_bib0057","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","article-title":"Statements from the Taormina expert meeting on occult hepatitis B virus infection","volume":"49","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2022.101892_bib0058","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1751-553X.2008.01092.x","article-title":"Sensitivity and specificity of Anti-HBc screening assays-which assay is best for blood donor screening?","volume":"31","author":"Hourfar","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clinre.2022.101892_bib0059","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tracli.2003.12.003","article-title":"Should HBV DNA NAT replace HBsAg and\/or anti-HBc screening of blood donors?","volume":"11","author":"Busch","year":"2004","journal-title":"Transfus Clin Biol J La Soc Fr Transfus Sang"},{"key":"10.1016\/j.clinre.2022.101892_bib0060","first-page":"399","article-title":"Uncovering occult hepatitis B in blood donations: a tale of two worlds","volume":"17","author":"Prati","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.clinre.2022.101892_bib0061","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/vox.12770","article-title":"Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015)","volume":"114","author":"Fiedler","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.clinre.2022.101892_bib0062","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s10903-017-0585-5","article-title":"Medical care, screening and regularization of sub-Saharan irregular migrants affected by hepatitis B in France and Italy","volume":"20","author":"Santilli","year":"2018","journal-title":"J Immigr Minor Heal"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:50Z","timestamp":1761895910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740122000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2210740122000353"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2022.101892","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of occult hepatitis B virus infection among subjects with isolated hepatitis B core antibodies: Results from a 3-year survey in an Italian tertiary-care hospital","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2022.101892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101892"}}